Because of the low price of microcap stocks, they can sometime yield significantly higher than average returns when there's buying momentun. Take for example, GENova Biotherapeutics, a company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The stock began to break out of its trading range on the 4th of September when it opened at $.10. It has closed higher for the past six consecutive days. It reached an intraday high of $.62 today, a yield of 520% in seven days.
Investing in microcap stocks is highly speculative and can also be extremely risky so make sure you perform proper due diligence and don't invest unless you can afford to lose your entire investment. For those who understand the risk/reward potential, investing in microcap stocks can be very rewarding.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment